Ginseng Panaxoside Rb1 Reduces Body Weight in Diet-Induced Obese Mice

Cell Biochemistry and Biophysics

Volumn 68, Issue 1, 2014, Pages 189-194

  Lin, Ning ^a   Cai, Dong Lian ^b   Jin, Di ^b   Chen, Yi ^a   Shi, Jiao Jiao ^a  

^a CHENGDU MILITARY GENERAL HOSPITAL   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Diet induced obesity; Diet resistant mice; Ginsenoside Rb1; Hypothalamus; Neuropeptide Y, peptide YY

Indexed keywords

MURINAE; MUS; PANAX GINSENG;

GINSENOSIDE; GINSENOSIDE RB 1; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR; PEPTIDE YY;

ANIMAL; ARTICLE; BLOOD; BODY WEIGHT; C57BL MOUSE; CHEMISTRY; COMPARATIVE STUDY; DIET; DRUG ADMINISTRATION; DRUG EFFECT; GENETICS; GLUCOSE BLOOD LEVEL; INTRAPERITONEAL DRUG ADMINISTRATION; LIPID DIET; MALE; METABOLISM; MOUSE; MOUSE MUTANT; OBESITY; PANAX; PATHOLOGY;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIET; DIET, HIGH-FAT; DRUG ADMINISTRATION SCHEDULE; GINSENOSIDES; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; NEUROPEPTIDE Y; OBESITY; PANAX; PEPTIDE YY; RECEPTORS, NEUROPEPTIDE Y;

EID: 84891623701     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-013-9688-3     Document Type: Article

References (46)

1. Leonhardt, M., Hrupka, B., & Langhans, W. (1999). New approaches in the pharmacological treatment of obesity. European Journal of Nutrition, 38, 1-13.
2. Grundy, S. M. (1998). Multifactorial causation of obesity: Implications for prevention. American Journal of Clinical Nutrition, 1998(67), 563S-572S.
3. Rebuffe-Scrive, M., Surwit, R., Feinglos, M., Kuhn, C., & Rodin, J. (1993). Regional fat distribution and metabolism in a new mouse model (C57BL/6 J) of non-insulin-dependent diabetes mellitus. Metabolism, 42, 1405-1409.
4. Astrup, A., Buemann, B., Western, P., Toubro, S., Raben, A., & Christensen, N. J. (1994). Obesity as an adaptation to a high-fat diet: Evidence from a cross-sectional study. American Journal of Clinical Nutrition, 59, 350-355.
5. Portillo, M. P., Simon, E., Garcia-Calonge, M. A., & Del Barrio, A. S. (1999). Effect of high-fat diet on lipolysis in isolated adipocytes from visceral and subcutaneous WAT. European Journal of Nutrition, 38, 177-182.
6. Morton, G. J., Cummings, D. E., Baskin, D. G., Barsh, G. S., & Schwartz, M. W. (2006). Central nervous system control of food intake and body weight. Nature, 443, 289-295.
7. Kalra, S. P., Dube, M. G., Sahu, A., Phelps, C. P., & Kalra, P. S. (1991). Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proceedings of the National Academy of Sciences USA, 88, 10931-10935.
8. Stanley, B. G., Kyrkouli, S. E., & Leibowitz, S. F. (1986). Neuropeptide Y chronically injected into the hypothalamus: A powerful neurochemical inducer of hyperphagia and obesity. Peptides, 7, 1189-1192.
9. Adrian, T. E., Ferri, G. L., Bacarese-Hamilton, A. J., Fuessl, H. S., Polak, J. M., & Bloom, S. R. (1985). Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology, 89, 1070-1077.
10. Batterham, R. L., Cowley, M. A., Small, C. J., Herzog, H., Cohen, M. A., Dakin, C. L., et al. (2002). Gut hormone PYY(3-36) physiologically inhibits food intake. Nature, 418, 650-654.
11. Batterham, R. L., & Bloom, S. R. (2003). The gut hormone peptide YY regulates appetite. Annals of the New York Academy of Sciences, 994, 162-168.
12. Lynch, D. R., Walker, M. W., Miller, R. J., & Snyder, S. H. (1989). Neuropeptide Y receptor binding sites in rat brain: Differential autoradiographic localizations with 125I-peptide YY and 125I-neuropeptide Y imply receptor heterogeneity. Journal of Neuroscience, 9, 2607-2619.
13. Cheng, Y., Shen, L. H., & Zhang, J. T. (2005). Anti-amnestic and anti-aging effects of ginsenoside Rg1 and Rb1 and its mechanism of action. Acta Pharmacologica Sinica, 26, 143-149.
14. Xue, J. F., Liu, Z. J., Hu, J. F., Chen, H., Zhang, J. T., & Chen, N. H. (2006). Ginsenoside Rb1 promotes neurotransmitter release by modulating phosphorylation of synapsins through a cAMP-dependent protein kinase pathway. Brain Research, 1106, 91-98.
15. Seo, J. Y., Lee, J. H., Kim, N. W., Her, E., Chang, S. H., Ko, N. Y., et al. (2005). Effect of a fermented ginseng extract, BST204, on the expression of cyclooxygenase-2 in murine macrophages. International Immunopharmacology, 5, 929-936.
16. Kim, J. H., Hahm, D. H., Yang, D. C., Kim, J. H., Lee, H. J., & Shim, I. (2005). Effect of crude saponin of Korean red ginseng on high-fat diet-induced obesity in the rat. Journal of Pharmacological Sciences, 97, 124-131.
17. Kim, S. H., & Park, K. S. (2003). Effects of Panax ginseng extract on lipid metabolism in humans. Pharmacological Research, 48, 511-513.
18. Xie, J. T., Wang, C. Z., Ni, M., Wu, J. A., Mehendale, S. R., Aung, H. H., et al. (2007). American ginseng berry juice intake reduces blood glucose and body weight in ob/ob mice. Journal of Food Science, 72, S590-S594.
19. Yeo, C. R., Yang, C., Wong, T. Y., & Popovich, D. G. (2011). A quantified ginseng (Panax ginseng C. A. Meyer) extract influences lipid acquisition and increases adiponectin expression in 3T3-L1 cells. Molecules, 16, 477-492.
20. Yeo, C. R., Lee, S. M., & Popovich, D. G. (2011). Ginseng (Panax quinquefolius) reduces cell growth, lipid acquisition and increases adiponectin expression in 3T3-L1 Cells. Evidence-Based Complementary and Alternative Medicine, 2011, 610625.
21. Park, S., Ahn, I. S., Kwon, D. Y., Ko, B. S., & Jun, W. K. (2008). Ginsenosides Rb1 and Rg1 suppress triglyceride accumulation in 3T3-L1 adipocytes and enhance beta-cell insulin secretion and viability in Min6 cells via PKA-dependent pathways. Bioscience, Biotechnology, and Biochemistry, 72, 2815-2823.
22. Huang, X. F., Han, M., & Storlien, L. H. (2004). Differential expression of 5-HT(2A) and 5-HT(2C) receptor mRNAs in mice prone, or resistant, to chronic high-fat diet-induced obesity. Brain Research Molecular Brain Research, 127, 39-47.
23. Levin, B. E., & Keesey, R. E. (1998). Defense of differing body weight set points in diet-induced obese and resistant rats. American Journal of Physiology, 274, R412-R419.
24. Xin, X., Storlien, L. H., & Huang, X. F. (2000). Hypothalamic c-fos-like immunoreactivity in high-fat diet-induced obese and resistant mice. Brain Research Bulletin, 52, 235-242.
25. Huang, X. F., Yu, Y., Li, Y., Tim, S., Deng, C., & Wang, Q. (2008). Ventromedial hypothalamic NPY Y2 receptor in the maintenance of body weight in diet-induced obesity in mice. Neurochemical Research, 33, 1881-1888.
26. Yamamoto, M., Kumagai, A., & Yamamura, Y. (1983). Plasma lipid-lowering and lipogenesis-stimulating actions of ginseng saponins in tumor-bearing rats. American Journal of Chinese Medicine, 11, 88-95.
27. Attele, A. S., Zhou, Y. P., Xie, J. T., Wu, J. A., Zhang, L., Dey, L., et al. (2002). Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes, 51, 1851-1858.
28. Sotaniemi, E. A., Haapakoski, E., & Rautio, A. (1995). Ginseng therapy in non-insulin-dependent diabetic patients. Diabetes Care, 18, 1373-1375.
29. Yun, S. N., Moon, S. J., Ko, S. K., Im, B. O., & Chung, S. H. (2004). Wild ginseng prevents the onset of high-fat diet induced hyperglycemia and obesity in ICR mice. Archives of Pharmacal Research, 27, 790-796.
30. Chung, S. H., Choi, C. G., & Park, S. H. (2001). Comparisons between white ginseng radix and rootlet for antidiabetic activity and mechanism in KKAy mice. Archives of Pharmacal Research, 24, 214-218.
31. Park, M. Y., Lee, K. S., & Sung, M. K. (2005). Effects of dietary mulberry, Korean red ginseng, and banaba on glucose homeostasis in relation to PPAR-alpha, PPAR-gamma, and LPL mRNA expressions. Life Sciences, 77, 3344-3354.
32. Shang, W., Yang, Y., Zhou, L., Jiang, B., Jin, H., & Chen, M. (2008). Ginsenoside Rb1 stimulates glucose uptake through insulin-like signaling pathway in 3T3-L1 adipocytes. Journal of Endocrinology, 198, 561-569.
33. Hansen, M. J., Ball, M. J., & Morris, M. J. (2001). Enhanced inhibitory feeding response to alpha-melanocyte stimulating hormone in the diet-induced obese rat. Brain Research, 892, 130-137.
34. Wilding, J. P., Gilbey, S. G., Mannan, M., Aslam, N., Ghatei, M. A., & Bloom, S. R. (1992). Increased neuropeptide Y content in individual hypothalamic nuclei, but not neuropeptide Y mRNA, in diet-induced obesity in rats. Journal of Endocrinology, 132, 299-304.
35. Gehlert, D. R. (1999). Role of hypothalamic neuropeptide Y in feeding and obesity. Neuropeptides, 1999(33), 329-338.
36. Zarjevski, N., Cusin, I., Vettor, R., Rohner-Jeanrenaud, F., & Jeanrenaud, B. (1993). Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology, 133, 1753-1758.
37. Lin, H. C., & Chey, W. Y. (2003). Cholecystokinin and peptide YY are released by fat in either proximal or distal small intestine in dogs. Regulatory Peptides, 114, 131-135.
38. Nguyen, A. D., Herzog, H., & Sainsbury, A. (2011). Neuropeptide Y and peptide YY: Important regulators of energy metabolism. Current opinion in Endocrinology, Diabetes, and Obesity, 18, 56-60.
39. Chen, C. H., & Rogers, R. C. (1997). Peptide YY and the Y2 agonist PYY-(13-36) inhibit neurons of the dorsal motor nucleus of the vagus. American Journal of Physiology, 273, R213-R218.
40. le Roux, C. W., Batterham, R. L., Aylwin, S. J., Patterson, M., Borg, C. M., Wynne, K. J., et al. (2006). Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology, 147, 3-8.
41. Batterham, R. L., Cohen, M. A., Ellis, S. M., le Roux, C. W., Withers, D. J., Frost, G. S., et al. (2003). Inhibition of food intake in obese subjects by peptide YY3-36. New England Journal of Medicine, 349, 941-948.
42. Boey, D., Lin, S., Enriquez, R. F., Lee, N. J., Slack, K., Couzens, M., et al. (2008). PYY transgenic mice are protected against diet-induced and genetic obesity. Neuropeptides, 42, 19-30.
43. Batterham, R. L., Ffytche, D. H., Rosenthal, J. M., Zelaya, F. O., Barker, G. J., Withers, D. J., et al. (2007). PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans. Nature, 450, 106-109.
44. Nah, S. Y., Kim, D. H., & Rhim, H. (2007). Ginsenosides: Are any of them candidates for drugs acting on the central nervous system? CNS Drug Reviews, 13, 381-404.
45. Chang, Y., Huang, W. J., Tien, L. T., & Wang, S. J. (2008). Ginsenosides Rg1 and Rb1 enhance glutamate release through activation of protein kinase A in rat cerebrocortical nerve terminals (synaptosomes). European Journal of Pharmacology, 578, 28-36.
46. Chen, C. F., Chiou, W. F., & Zhang, J. T. (2008). Comparison of the pharmacological effects of Panax ginseng and Panax quinquefolium. Acta Pharmacologica Sinica, 29, 1103-1108.